Yes! I want to help! 
The most common form of dementia affects approximately 7.8 million people in the European Union. A Swedish study has shown that a blood test can detect Alzheimer’s disease with 90% accuracy.
Research also indicates that newly diagnosed dementia patients are 29% less likely to die if they continue to engage in physical exercise.
New treatments for certain Alzheimer’s patients have also been approved this year.
For example, European regulatory authorities have given the green light to the Alzheimer’s drug Lecanemab, which was initially rejected. Clinical trials have demonstrated that the drug slows cognitive decline associated with the disease.
They need your help and very, very urgently!
